See more : Alm. Brand A/S (ABDBY) Income Statement Analysis – Financial Results
Complete financial analysis of PT Metro Healthcare Indonesia Tbk (CARE.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Metro Healthcare Indonesia Tbk, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- The National Company for Glass Industries (2150.SR) Income Statement Analysis – Financial Results
- Micro-Tech (Nanjing) Co., Ltd. (688029.SS) Income Statement Analysis – Financial Results
- PT Sunter Lakeside Hotel Tbk (SNLK.JK) Income Statement Analysis – Financial Results
- PHP Ventures Acquisition Corp. (PPHPR) Income Statement Analysis – Financial Results
- PT FAP Agri Tbk (FAPA.JK) Income Statement Analysis – Financial Results
PT Metro Healthcare Indonesia Tbk (CARE.JK)
Industry: Medical - Care Facilities
Sector: Healthcare
About PT Metro Healthcare Indonesia Tbk
PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia. It owns and operates 7 hospitals. The company was founded in 2015 and is based in Tangerang, Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Anugrah Kasih Rajawali.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 242.68B | 233.97B | 290.93B | 216.30B | 154.08B | 87.21B | 31.20B | 0.00 |
| Cost of Revenue | 153.03B | 137.74B | 145.00B | 113.40B | 78.41B | 49.55B | 16.33B | 0.00 |
| Gross Profit | 89.65B | 96.23B | 145.93B | 102.89B | 75.66B | 37.66B | 14.86B | 0.00 |
| Gross Profit Ratio | 36.94% | 41.13% | 50.16% | 47.57% | 49.11% | 43.18% | 47.65% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.93B | 14.94B | 33.15B | 22.58B | 11.66B | 7.83B | 2.68B | 0.00 |
| Selling & Marketing | 332.36M | 621.10M | 204.18M | 603.21M | 905.82M | 313.90M | 0.00 | 0.00 |
| SG&A | 125.19B | 15.56B | 33.35B | 23.18B | 12.57B | 8.14B | 2.68B | 175.00M |
| Other Expenses | 0.00 | 141.27B | 98.48B | 95.57B | 54.42B | -1.83B | 1.61B | 175.00M |
| Operating Expenses | 125.79B | 156.82B | 131.84B | 118.75B | 66.99B | 41.14B | 14.02B | 175.00M |
| Cost & Expenses | 278.82B | 294.56B | 276.84B | 232.16B | 145.40B | 90.69B | 30.35B | 175.00M |
| Interest Income | 6.62B | 31.78B | 15.78B | 40.43B | 4.66B | 2.42B | 65.52M | 0.00 |
| Interest Expense | 76.86B | 89.33B | 25.43B | 11.31B | 19.25B | 23.17B | 13.56B | 0.00 |
| Depreciation & Amortization | 21.58B | 22.88B | 17.30B | 12.12B | 8.11B | 7.10B | 2.26B | 7.24B |
| EBITDA | -7.68B | 19.71B | 31.40B | 37.22B | 5.84B | 4.21B | 2.52B | 7.06B |
| EBITDA Ratio | -3.16% | -12.56% | 10.06% | 11.60% | 7.27% | -3.32% | 8.09% | 0.00% |
| Operating Income | -36.14B | -60.59B | 14.10B | -15.86B | 8.67B | -3.48B | 847.44M | -175.00M |
| Operating Income Ratio | -14.89% | -25.90% | 4.85% | -7.33% | 5.63% | -3.99% | 2.72% | 0.00% |
| Total Other Income/Expenses | -69.98B | -32.72B | -7.59B | 29.31B | -30.20B | -22.58B | -11.88B | 10.61B |
| Income Before Tax | -106.12B | -93.32B | 6.51B | 13.79B | -21.52B | -26.06B | -11.04B | 10.43B |
| Income Before Tax Ratio | -43.73% | -39.88% | 2.24% | 6.38% | -13.97% | -29.88% | -35.37% | 0.00% |
| Income Tax Expense | 4.57B | 288.46M | 332.91M | -375.14M | 2.76B | 1.81B | 527.13M | 8.13M |
| Net Income | -110.92B | -93.60B | 6.10B | 14.31B | -24.29B | -27.49B | -11.52B | 10.42B |
| Net Income Ratio | -45.71% | -40.01% | 2.10% | 6.62% | -15.76% | -31.52% | -36.92% | 0.00% |
| EPS | -3.34 | -2.82 | 0.18 | 0.43 | -0.73 | -0.83 | -0.35 | 0.31 |
| EPS Diluted | -3.34 | -2.82 | 0.18 | 0.43 | -0.73 | -0.83 | -0.35 | 0.31 |
| Weighted Avg Shares Out | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B |
| Weighted Avg Shares Out (Dil) | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B | 33.25B |
Source: https://incomestatements.info
Category: Stock Reports